Viva is dedicated to providing a broad range of high-quality pharmaceutical discovery and development capabilities and fully-integrated services from initial discoveries to investigational new drug applications for pharmaceutical and biotechnology companies.
Leading the multidisciplinary expertise of our scientific staffs is a team of experienced medicinal chemists and discovery biologists from top international pharmaceutical and biotech companies such as Pfizer, Merck, Albert labs in structure biology (Dr. Cheney Mao), cell biology (Dr. Derek Ren), medicinal chemistry (Dr. Zhixiong Ye), chemistry (Dr. Lei Fu), DMPK (Dr. Shawn Cheng), and in vivo pharmacology (Dr. Xiaohong Liu). We have strong project management and scientific expertise to handle drug discovery projects of any complexity in a range of therapeutic areas.
.png)
Our services include but are not limited to:
Target Validation:
Cell-based assays
Mechanism-based animal models
Design and validation of biochemical and cellular screening
Lead Identification and Optimization:
Screening hits-to-leads
Fragment library
Library design and parallel synthesis
Structure activity relationship
Computational chemistry modeling and structure-based design
Drug metabolism and pharmacokinetics:
Bioavailability, DMPK, biodistribution
Predictive ADMET assays
Radio-labeled synthesis
Pharmacology, Efficacy, and Predictive ADMET:
In vitro and in vivo efficacy
Custom animal models
Mechanism-of-action studies
We have the knowledge required to integrate all of these scientific functions into a team, and we are committed to helping our clients achieve their goals. Our operations in Shanghai contain modern and well-equipped facilities to offer fast, flexible, cost efficient, and client-oriented services.
For other services you might be interested in, please inquire online.